| Literature DB >> 26491263 |
Paul F Cook1, Jane M Carrington2, Sarah J Schmiege1, Whitney Starr3, Blaine Reeder1.
Abstract
PURPOSE: Medication adherence is a major challenge in HIV treatment. New mobile technologies such as smartphones facilitate the delivery of brief tailored messages to promote adherence. However, the best approach for tailoring messages is unknown. Persons living with HIV (PLWH) might be more receptive to some messages than others based on their current psychological state.Entities:
Keywords: HIV; adherence; communication; feasibility; technology
Year: 2015 PMID: 26491263 PMCID: PMC4599065 DOI: 10.2147/PPA.S88222
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Message tailoring dimensions
| Construct | What is assessed to determine tailoring | Difference between tailored message versions | Specific matching prediction and relevant theory of health behavior | Average construct validity rating of ten tailored messages |
|---|---|---|---|---|
| Control beliefs | High vs low sense of control over problems | Emphasis on reasons for change (“think about”) vs actions to take (“do”) | Problem-solving focus → ↑ adherence for high control beliefs; reasons for change better for low control beliefs (Prochaska and DiClemente’s transtheoretical model | M =3.58 (SD =0.19) |
| Mood | Level of positive emotional arousal (high vs low) | Focus on feared outcomes (permanent vs short-term), and use of affect-inducing words | Feared consequences → ↑ adherence for high (positive) mood; lower-fear presentation better for low (negative) mood (Leventhal’s illness perception model | M =3.86 (SD =0.31) |
| Situational stress | Level of current stress (high vs low) from multiple sources | Deep focus (content) vs surface focus (vivid images, expert quotes, personal relevance) | For high stress, surface focus → ↑ adherence; content focus better for low stress when people process information more deeply (Lazarus and Folkman’s coping theory | M =3.69 (SD =0.29) |
| Coping | Approach (domain of gains) vs avoidance (domain of losses) | Emphasis on benefits of behavior change vs costs of not changing behavior | Gain frame → ↑ adherence for high (active) coping; loss frame better for low (passive) coping (Kahneman and Tversky’s prospect theory | M =3.91 (SD =0.12) |
| Social support | Perceived current social support (+)and stigma (−) | Focus on self vs others in reasons for behavior change | Other-focus → ↑ adherence if support is seen as high; self-focus better if support is low (Bronfenbrenner’s socio-ecological model | M =3.72 (SD =0.26) |
Notes: Construct validity ratings were made by 15 independent experts in health behavior change research, using a scale from 1= “not relevant” to 4= “very relevant and succinct”. Ratings were averaged across experts, and across ten different base messages corresponding to different barriers to adherence. Experts also gave a rating of 3.84 points for the messages’ overall integration and consistency, and 3.89 points for their relevance to ART adherence and clinical utility, on the same 4-point scale. The ten barriers identified through consultation with HIV primary care experts in a previous stage of development were: 1) low perceived importance of treatment, 2) lack of confidence in treatment, 3) adverse effects of treatment, 4) feeling healthy, 5) feeling sick, 6) lack of financial resources, 7) treatment complexity, 8) stigma, 9) alcohol or other drug use, and 10) forgetting.
Abbreviations: vs, versus; M, mean; SD, standard deviation; HIV, human immunodeficiency virus.
Figure 1CONSORT diagram showing recruitment, enrollment, and retention.
Abbreviations: PLWH, persons living with HIV; HIV, human immunodeficiency virus; MEMS, medication event monitoring system; CONSORT, Consolidated Standards of Reporting Trials.
Participant demographics by order of study conditions
| Variable | AB condition order (matched first) | BA condition order (mismatched first) | Significant difference? Yes/no |
|---|---|---|---|
| Age, years | M =43.7 (SD =5.87) | M =41.8 (SD =9.23) | No: |
| Sex | 35% women (6/17) | 10% women (2/20) | Yes: |
| Race/ethnicity | 47% non-White (8/17) | 55% non-White (11/20) | No: |
| Sexual orientation | 29% GLBT (5/17) | 85% GLBT (17/20) | Yes: |
| Years of education | M =12.9 (SD =1.45) | M =13.0 (SD =2.54) | No: |
| Baseline MEMS adherence (%) | M =72% (SD =22%) | M =87% (SD =20%) | No: |
Abbreviations: MEMS, medication event monitoring system; SD, standard deviation; GLBT, gay, lesbian, bisexual, or transgender; M, mean.
Figure 2Example of tailored messaging intervention.
Abbreviation: meds, medications.
Summary statistics for self-report feasibility measures
| Variable | N | Possible range | Minimum | Maximum | |
|---|---|---|---|---|---|
| Acceptance | 14 | 0–100 | 85.3 (17.9) | 49 | 100 |
| Ease of use | 25 | 1–7 | 5.96 (1.06) | 3.24 | 7.00 |
| Usefulness | 5 | 0–4 | 2.79 (0.23) | 2.50 | 3.13 |
| Would do it again | 5 | 0–4 | 3.00 (0.00) | 3.00 | 3.00 |
| Would recommend to a friend | 5 | 0–4 | 3.40 (0.55) | 3.00 | 4.00 |
Notes: N varies by analysis because the technology acceptance questionnaire was completed by participants at the end of the baseline phase for the first two measures (with some missing data on the acceptance item), and the tailored messaging survey was completed at the end of the intervention phase, with sample size affected by attrition. Results on the perceived usefulness measures are therefore less reliable.
Abbreviations: SD, standard deviation; N, number of responses; M, mean.
Figure 3Change in adherence over time.
Notes: AB order = matched, then mismatched messages; BA order = mismatched, then matched messages. Covariates in the model are evaluated at the following average values: sex =0.72 (1= male, 0= female); baseline MEMS =0.8354; number of days with observations =7.48 days.
Abbreviation: MEMS, medication event monitoring system.